S. Rosero

发表

The QT Scale: A Weight Scale Measuring the QTc Interval

R. Pallàs-Areny, W. Zareba, J. Couderc, 2017, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Deep Phenotyping of Parkinson’s Disease

Max A. Little, Mohammad Rafayet Ali, Alistair M. Glidden, 2020, Journal of Parkinson's disease.

Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome.

Wojciech Zareba, Arthur J Moss, A. Moss, 2007, American heart journal.

Direct Left Atrial Pressure Monitoring in Severe Heart Failure: Long-Term Sensor Performance

William T. Abraham, Saibal Kar, Leslie Saxon, 2010, Journal of cardiovascular translational research.

Prognostic Usefulness of Systolic Blood Pressure One-Year Following Cardiac Resynchronization Therapy (from MADIT-CRT).

W. Zareba, I. Goldenberg, S. McNitt, 2019, The American journal of cardiology.

Hospitalization for Heart Failure and Subsequent Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.

W. Zareba, I. Goldenberg, S. McNitt, 2021, JACC. Clinical electrophysiology.

Utility of Cardiovascular Implantable Electronic Device-Derived Patient Activity to Predict Clinical Outcomes.

W. Zareba, I. Goldenberg, K. Stein, 2021, Heart rhythm.

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Wojciech Zareba, Arthur J Moss, Scott McNitt, 2008, Journal of the American College of Cardiology.

Ambulatory ECG monitoring in atrial fibrillation management.

Wojciech Zareba, Brian Olshansky, Valentina Kutyifa, 2013, Progress in cardiovascular diseases.

Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy).

A. Moss, W. Zareba, I. Goldenberg, 2016, Heart rhythm.

Novel Compound Heterozygous Mutations in the KCNQ1 Gene Associated with Autosomal Recessive Long QT Syndrome (Jervell and Lange‐Nielsen syndrome)

A. Moss, W. Zareba, M. Qi, 2003, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Effect of biventricular pacing during a ventricular sensed event.

Abrar H. Shah, J. Daubert, Burr Hall, 2009, American Journal of Cardiology.

Update on implantable cardioverter defibrillator trials

Abrar H. Shah, J. Daubert, S. Rosero, 2004, Current cardiology reports.

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)

W. Zareba, I. Goldenberg, S. McNitt, 2020, Heart rhythm O2.

Electrocardiographic findings in patients with diphenhydramine overdose.

A. Moss, W. Zareba, J. Konecki, 1997, The American journal of cardiology.

A Brief Overview of Supraventricular Tachycardias

S. Rosero, 2015 .

Reassessing the role of Antitachycardia Pacing in Fast Ventricular Arrhythmias in Primary Prevention Implantable Cardioverter Defibrillator Recipients: Results from MADIT-RIT.

W. Zareba, J. Daubert, C. Schuger, 2020, Heart rhythm.

Long-Term Survival With Implantable Cardioverter-Defibrillator in Different Symptomatic Functional Classes of Heart Failure.

A. Moss, W. Zareba, I. Goldenberg, 2016, The American journal of cardiology.

Right Ventricular Dysfunction and the Incidence of Implantable Cardioverter‐Defibrillator Therapies

W. Zareba, J. Daubert, Burr Hall, 2009, Pacing and clinical electrophysiology : PACE.

AnaLysIs of Both sex and device specific factoRs on outcomes in pAtients with non-ischemic cardiomyopathy (BIO-LIBRA): Design and clinical protocol

W. Zareba, S. McNitt, M. Gleva, 2020, Heart rhythm O2.

Relation between resting heart rate and the risk of ventricular tachyarrhythmias in MADIT-RIT.

R. Beinart, I. Goldenberg, S. McNitt, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Predictors and Outcomes of Atrial Tachyarrhythmia among Patients with Implantable Defibrillators.

E. Heist, I. Goldenberg, S. McNitt, 2019, Heart rhythm.

Heart failure severity, inappropriate ICD therapy, and novel ICD programming: a MADIT‐RIT substudy

A. Moss, W. Zareba, J. Daubert, 2017, Pacing and clinical electrophysiology : PACE.

Need for pacing in patients who qualify for an implantable cardioverter‐defibrillator: Clinical implications for the subcutaneous ICD

W. Zareba, I. Goldenberg, S. McNitt, 2020, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc Interval: The Value of Sex, T-Wave Morphology, and Mutation Type

A. Moss, W. Zareba, P. Platonov, 2018, Circulation. Arrhythmia and electrophysiology.

Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.

S. Solomon, A. Moss, W. Zareba, 2013, Heart rhythm.

The Huntington's Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome Measure.

E. Dorsey, Alistair M Glidden, Jennifer S. Weinstein, 2022, Journal of Huntington's disease.

Sex Differences in the Risk of First and Recurrent Ventricular Tachyarrhythmias Among Patients Receiving an Implantable Cardioverter-Defibrillator for Primary Prevention

W. Zareba, I. Goldenberg, H. Klein, 2022, JAMA network open.

Effectiveness of Implantable Cardioverter-Defibrillators to Reduce Mortality in Patients With Long QT Syndrome.

W. Zareba, C. Seplaki, D. Rich, 2021, Journal of the American College of Cardiology.

Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT‐RIT substudy

A. Moss, W. Zareba, P. Veazie, 2017, American heart journal.

Sex Hormones and Repolarization Dynamics during the Menstrual Cycle in Women with Congenital Long QT Syndrome.

Derick R. Peterson, P. Kudenchuk, T. Rea, 2022, Heart rhythm.

Use of Oral Contraceptives in Women with Congenital Long QT Syndrome.

P. Kudenchuk, T. Rea, D. Arking, 2021, Heart rhythm.

Outcome by Sex in Patients With Long QT Syndrome With an Implantable Cardioverter Defibrillator

P. Kudenchuk, T. Rea, D. Arking, 2020, Journal of the American Heart Association.

Changes in paced signals may predict in‐hospital cardiac arrest

S. Nolan, S. Rosero, M. Attin, 2018, Pacing and clinical electrophysiology : PACE.

Ventricular Fibrillation Complicating Endomyocardial Biopsy of Transplanted Heart

S. Rosero, J. Alexis, H. Patel, 2013, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Syncope and Exercise‐Related Ventricular Tachycardia

A. Wilde, S. Rosero, David T. Huang, 2012, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients

Derick R. Peterson, S. Priori, A. Mazzanti, 2022, Frontiers in Cardiovascular Medicine.

Venous Thrombosis and Stenosis After Implantation of Pacemakers and Defibrillators

J. Daubert, Burr Hall, S. Rosero, 2005, Journal of Interventional Cardiac Electrophysiology.

Denaturing high-performance liquid chromatography quickly and reliably detects cardiac ion channel mutations in long QT syndrome.

A. Moss, M. Qi, Jennifer L. Robinson, 2003, Genetic testing.

Altered atrial, atrioventricular, and ventricular conduction in patients with the long QT syndrome caused by the DeltaKPQ SCN5A sodium channel gene mutation.

A. Moss, W. Zareba, J. Couderc, 2001, The American journal of cardiology.

Newer indications for permanent pacemakers

S. Rosero, T. Akiyama, 2000, Comprehensive therapy.

Lidocaine block of LQT-3 mutant human Na+ channels.

R. Kass, S. Rosero, R. An, 1996, Circulation research.

Insertable cardiac monitor‐guided early intervention to reduce atrial fibrillation burden following catheter ablation: Study design and clinical protocol (ICM‐REDUCE‐AF trial)

R. Strawderman, W. Zareba, I. Goldenberg, 2023, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Congenital long QT syndrome: considerations for primary care physicians.

A. Moss, W. Zareba, J. Daubert, 2008, Cleveland Clinic journal of medicine.

The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation Mechanistic and Therapeutic Synergism

Wojciech Zareba, A. John Camm, A. Camm, 2015, Circulation. Arrhythmia and electrophysiology.

Time-dependent risk of Fidelis lead failure.

Abrar H. Shah, A. Moss, W. Zareba, 2010, The American journal of cardiology.

Ranolazine Shortens Repolarization in Patients with Sustained Inward Sodium Current Due to Type‐3 Long‐QT Syndrome

A. Moss, W. Zareba, K. Schwarz, 2008, Journal of cardiovascular electrophysiology.

Device Therapy in Heart Failure

S. Rosero, M. Aktas, 2009 .

Safety and Efficacy of Flecainide in Subjects with Long QT‐3 Syndrome (ΔKPQ Mutation): A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial

A. Moss, W. Zareba, J. Daubert, 2005, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Mexiletine in Myotonic Dystrophy Type 1

W. Zareba, R. Moxley, M. Mcdermott, 2020, Neurology.

Cardiac Resynchronization Therapy and Risk of Recurrent Hospitalizations in Patients Without Left Bundle Branch Block

S. Solomon, W. Zareba, I. Goldenberg, 2020, Circulation. Heart failure.

Atrial Fibrillation in Long QT Syndrome by Genotype.

W. Zareba, P. Platonov, S. McNitt, 2019, Circulation. Arrhythmia and electrophysiology.

Quantitative T‐wave morphology assessment from surface ECG is linked with cardiac events risk in genotype‐positive KCNH2 mutation carriers with normal QTc values

W. Zareba, P. Platonov, S. McNitt, 2019, Journal of cardiovascular electrophysiology.

Patient reported impact of symptoms in amyotrophic lateral sclerosis (PRISM-ALS): A national, cross-sectional study

M. Benatar, J. Wuu, J. Statland, 2022, EClinicalMedicine.

Asthma and the risk of cardiac events in the Long QT syndrome. Long QT Syndrome Investigative Group.

A. Moss, W. Zareba, M. Andrews, 1999, The American journal of cardiology.

Primary prevention with the implantable cardioverter-defibrillator in high-risk long-QT syndrome patients

A. Moss, W. Zareba, I. Goldenberg, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator.

W. Zareba, I. Goldenberg, S. McNitt, 2022, JACC. Clinical electrophysiology.

Quality of life predicting long-term outcomes in cardiac resynchronization therapy patients.

W. Zareba, B. Merkely, A. Kosztin, 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Patient-Reported Impact of Symptoms in Crohn's Disease

Elizabeth A. Luebbe, Jennifer S. Weinstein, C. Heatwole, 2022, The American journal of gastroenterology.

Polypharmacy prior to in-hospital cardiac arrest among patients with cardiopulmonary diseases: A pilot study

O. Intrator, S. Rosero, R. Block, 2020, Resuscitation plus.

Gene‐Specific Therapy for Long QT Syndrome

A. Moss, W. Zareba, Jennifer L. Robinson, 1997 .

Predictors of Atrial Fibrillation During Long‐Term Implantable Cardiac Monitoring Following Cryptogenic Stroke

I. Goldenberg, S. McNitt, S. Rosero, 2020, Journal of the American Heart Association.

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease

W. Zareba, C. Schuger, I. Goldenberg, 2023, Frontiers in cardiovascular medicine.

Arrhythmic and Mortality Outcomes Among Ischemic Versus Nonischemic Cardiomyopathy Patients Receiving Primary Implantable Cardioverter-Defibrillator Therapy.

W. Zareba, J. Daubert, I. Goldenberg, 2021, JACC. Clinical electrophysiology.